# PK/PD Study of YZJ-1139

> **NCT06685341** · PHASE1 · COMPLETED · sponsor: **Shanghai Haiyan Pharmaceutical Technology Co., Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Insomnia

## Interventions

- **DRUG:** YZJ-1139
- **DRUG:** Placebo
- **DRUG:** Zolpidem

## Key facts

- **NCT ID:** NCT06685341
- **Lead sponsor:** Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-07
- **Primary completion:** 2019-04-10
- **Final completion:** 2019-11-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06685341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06685341, "PK/PD Study of YZJ-1139". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06685341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*